Abstract:OBJECTIVES:To compare the clinical effect of low molecular weight heparin (LMWH) and regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT) after heart valve replacement. METHODS:Retrospective analysis of clinical data from 60 patients undergoing continuous renal replacement therapy after heart valve replacement in Peking University Shenzhen Hospital from January 2015 to July 2019, including 35 males and 25 females, aged (58.83 ±16.36) years. The patients were divided into a LMWH group and a RCA group according to the anticoagulation regimen, with 30 patients in each group. The 24 h postoperative drainage volume (pericardium, mediastinum), postoperative ventilator use time and ICU stay time, incidence of postoperative respiratory tract bleeding and gastrointestinal bleeding, postoperative skin ecchymosis incidence and mortality between the 2 groups were compared; the thromboplastin time (APTT), fibrinogen (FIB), thrombin time (TT), prothrombin time (PT), international normalized ratio (INR), and PLT between the 2 groups after anticoagulation treatment were compared; the service life of dialysis filters and CRRT time between the 2 groups were compared; and the levels of urea nitrogen and serum creatinine between the 2 groups before and after treatment were also compared. RESULTS:After anticoagulant treatment, the RCA group had less 24 h postoperative drainage volume than the LMWH group, shorter ventilator use time, ICU stay time, and hospitalization days than the LMWH group, and lower respiratory tract bleeding and gastrointestinal bleeding incidence than the LMWH group, with significant differences (all P<0.05); there was no significant difference in the incidence of skin ecchymosis and mortality after treatment between the 2 groups (all P>0.05); there was no significant difference in APTT, FIB, and TT between the 2 groups (all P>0.05); the PT and INR of the RCA group were higher than those in the LMWH group, while the PLT of RCA group was lower than that in the LMWH group, with significant differences (all P<0.05); there was no significant difference in CRRT time between the two groups (P=0.073). After the treatment, there were no significant differences in urea nitrogen and serum creatinine levels between the 2 groups (all P>0.05). CONCLUSIONS:CRRT after cardiac valve replacement with RCA can effectively reduce pericardial and mediastinal drainage, reduce the risk of bleeding, shorten the time of ventilator use and ICU stay, and promote postoperative recovery of patients, which have positive significance for reducing the burden on patients and their families.

Efficacy Observation of Bridging Anticoagulation of Low Molecular Weight Heparin after Cardic Valve Replacement in the Early Stage

Blood Conservation Strategies in Cardiac Valve Replacement

[Clinical Study of Anticoagulation with Warfarin and Heparin in Patients after Mechanical Valve Replacement].

Progress on low molecular weight heparin for patients with heart valve replacement

The Anticoagulant Therapy and International Normalized Ratio Monitoring after the Mechanical Heart Valve Replacement

Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

Comparison of Low-Molecular-weight-heparin and Unfractionated Heparin for Acute PTE

Safety of Preoperative Heparin for Prevention of Thrombus in Patients Undergoing Thoracoscopic Surgery

New Internet-Based Warfarin Anticoagulation Management Approach After Mechanical Heart Valve Replacement: Prospective, Multicenter, Randomized Controlled Trial

Anticoagulation of Warfarin Therapy in Patients after Mechanical Valve Implantation

Comparison of different anticoagulation methods in perioperative period of pacemaker im-plantation for atrial fibrillation patients receiving long-term warfarin therapy

Inverse Relationship of Bleeding Risk with Clot Burden During Pulmonary Embolism Treatment with LMW Heparin.

Comparison of Curative Effect Between Different Anticoagulation Regimens in Continuous Renal Replacement Therapy after Cardiac Valve Replacement.

Late dysfunction of a mechanical aortic valve after long-term low molecular weight heparin therapy: a case report

Perioperative antithrombotic strategy in coronary intervention therapy for the patients with coronary heart disease treated with long-term warfarin anticoagulation

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study

Rationality and Impact Factors of Two Initial Dosage Regimen of Warfarin

Comparison of the effects on coagulation function and safety of bivalirudin and heparin in patients undergoing percutaneous coronary intervention: A randomized trial

Effect of continuity of care on anticoagulant therapy and quality of life after heart valve replacement: a systematic review and meta-analysis.

[Low-Molecular-weight Heparin for Preventing Deep-Vein Thrombosis after Total Joint Arthroplasty].

Safety and efficacy of using portable coagulation monitor for INR examination after left-sided mechanical prosthetic valve replacement